Synthesis, Characterization and Biological Screening of Some Novel Pyrazolinones

 

Kausik Ghosh, Arista Chaudhari* and DS Seth

School of Chemical Sciences, Department of Chemistry ST. John’s College, Agra-282002 (India).

*Corresponding Author E-mail: chaudhaaryarista@gmail.com

  

ABSTRACT

Some novel pyrazolinones were synthesized by the condensation of aryl hydrazone of ethylaceto acetate with N (4-butyl) phenyl malonamic acid hydrazide. All the title compounds were characterized on the basis of I.R spectra and elemental analysis. 

 

KEY WORDS: Synthesis, Ethylacetoacetate, Pyrazolones 

 


 

INTRODUCTION:

Pyrazolinones are oxo derivatives of pyrazoline. Pyrazolinone were effective anti-oxidant 1 for rubber and linseed oil and responsible for inhibition of odor formation in synthetic detergent2. They possess wide range of pharmacological activities as bacteriostatic3, bactericidal4, 5, fungicidal6, 7, anti-pyretic8, 9, analgesic10, anticoagulant11, anti-anthelmintic12, anti-rheumatic13, 14, germicidal15, etc.

    Your browser may not support display of this image.

4- (R) phenyl hydrazono- N’-4-butyl amino malonyl –3- methyl -2-pyrazolin-5-one.

 

Where, R= 2-CH3, 2-OC2H5, 4- NO2, 4-Cl, 4-CH3, 3, 4 (CH3)2; R’= -CH2-CH2- CH2-CH 

 

MATERIAL AND METHOD:

All reagents and solvents were procured from Sigma Aldrich. Melting Points were determined in open capillaries on Electro-thermal apparatus and were uncorrected. Infrared (IR) spectra were recorded on Perkin Elmer RX-1 using KBr wafers. 

 

General procedure for the synthesis of N (4-butyl) phenyl malonamic acid hydrzide:

3 ml of 4-butyl aniline and 6ml of diethylmalonate was refluxed for 1 hr. When dianillide get separated, filtrate was collected in china dish and concentrated by heating on boiling water bath. White sticky mass of ethyl –N-(4 butyl) malonamate was obtained and finally treated with petroleum ether. 2.6 gm of ethyl -N--(4 butyl) phenyl malonamate in 20 ml of ethanol was treated with 4 ml of hydrazine hydrate (98 %), white crystalline compound was obtained which was recrystallized from hot ethanol.

 

Synthesis of ethyl-2, 3 –dioxo butyrate -2- (substituted) phenyl hydrazone:

3 ml of substituted aniline was diazotized by adding conc. HCl (6 ml) and diluted with 6 ml distilled water and cooled to 0ºc. 10 ml NaNOsolution was added with constant stirring. Finally mixture of sodium acetate (1.5 gm) and ethylacetoacetate (2 ml) in 10 ml of ethanol was added. The solid which separated was filtered, washed with cold water and recrystallized with dilute ethanol. 

 

TABLE I  Pyrazolinones obtained by the condensation of ethyl 2-3, di –oxo butyrate 2- (R) phenyl hydrazone with N-(4 -butyl) phenyl malonamic acid hydrazide

 

S.N

R

 

Mol. Formula

M.PºC

Yield

%

Nitrogen %

Found       Cal

Carbon %

Found         Cal

Hydrogen %

Found     Cal 

I.R    v cm-1

1

2-Cl

 

C23H24O2N5Cl

 

171

48.05

15.62

15.43

60.89

60.85

5.19

5.29

3280  cm-1  (NH), 1649cm-1 (C=O),  1576 cm-1 (>C=N), 1541 cm-1  (N-N), 1349 cm-1 (-CH3 bonding),  1249 cm-1  (-C-N )

2

4- Cl

C23H24O2N5Cl

 

 

189

 

45.76

 

15.48

 

15.43

 

60.88

 

60.85

5.21

 

5.29

3284  cm-1  (NH), 1654 cm-1 (C=O),  1565 cm-1 (>C=N), 1531 cm-1  (N-N), 1335 cm-1 (-CH3 bonding),  1256 cm-1  (-C-N )

3

 

2-CH3

 

C24H27O2N5

 

 

193

50.35

16.25

16.16

66.56

 

66.50

6.29

 

6.23

3290  cm-1  (NH), 1660 cm-1 (C=O),  1592 cm-1 (>C=N), 1546 cm-1  (N-N), 1350 cm-1 (-CH3 bonding),  1260 cm-1  (-C-N )

4

4-CH3

C24H27O3N5

 

 

180

43.16

16.27

16.16

66.58

66.5

6.25

6.23

3296  cm-1  (NH), 1665 cm-1 (C=O),  1595 cm-1 (>C=N), 1550 cm-1  (N-N), 1358 cm-1 (-CH3 bonding),  1269 cm-1  (-C-N )

5

2-OC2H5

C24H29O4N5

 

 

171

44.84

15.59

15.52

63.85

63.80

6.49

6.43

3286  cm-1  (NH), 1687cm-1 (C=O),  1596 cm-1 (>C=N), 1566 cm-1  (N-N), 1359 cm-1 (-CH3 bonding),  1250 cm-1  (-C-N )

6

3,4-(CH3)

C25H29O3N5

 

200

46.51

15.72

15.65

67.17

67.11

6.53

6.48

3291  cm-1  (NH), 1673 cm-1 (C=O),  1584 cm-1 (>C=N), 1557 cm-1  (N-N), 1348 cm-1 (-CH3 bonding),  1279 cm-1  (-C-N )

7

4-NO2

C23H24O5N6

 

199

40.26

18.15

18.10

59.52

59.48

5.17

5.07

3287  cm-1  (NH), 1660 cm-1 (C=O),  1592 cm-1 (>C=N), 1568 cm-1  (N-N), 1340 cm-1 (-CH3 bonding),  1272 cm-1  (-C-N )

 


 

TABLE- II  Antibacterial activity screening of some of the compounds

S.N

Name of the compound

Concentration

In H gm/ml

                          Sensitivity

Pseudomonas

Stapphylococcus

E.coli

B.subtilis

1

4- (4- chloro) phenyl hydrazono- N’-4-Butyl amino malonyl –3- methyl -2-pyrazolin-5-one.

 

20

30

40

50

+2

+2

+3

+3

R

R

R

R

R

R

R

+1

R

R

R

R

2

4- ( 4- nitro) phenyl hydrazono- N’-4-Butyl amino malonyl –3- methyl -2-pyrazolin-5-one.

 

20

30

40

50

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

R

3

4- (4- methyl) phenyl hydrazono- N’-4-Butyl amino malonyl –3- methyl -2-pyrazolin-5-one.

 

20

30

40

50

R

R

R

R

R

R

R

+1

R

R

R

R

R

R

R

R

4

4- (3, 4-dimethyl) phenyl hydrazono- N’-4-Butyl amino malonyl –3- methyl -2-pyrazolin-5-one

20

30

40

50

R

R

R

R

R

R

R

R

R

R

R

+1

R

R

R

R

 

 


Synthesis of 4- (substituted) phenyl hydrazono- N’-4-Butyl amino malonyl –3- methyl -2-pyrazolin-5-one.

0.26 gm of ethyl-2, 3 –dioxo butyrate -2- (substituted) phenyl hydrazone (1 mol) and 0.24 gm N (4-butyl) phenyl malonamic acid hydrazide dissolved in 10 ml of ethanol was refluxed for 2 hrs using glacial acetic acid as catalyst and finally recrystallized from ethanol and purity has been checked by TLC using silica gel G plates in 10 % methanol/benzene.

 

RESULTS AND DISCUSSION:

The results of m. p. %Yield , %Nitrogen, %Carbon, % Hydrogen were discuss in table no. 1 and Antibacterial activity screening of some of the compounds was discuss in table 2.

 

ACKNOWLEDGEMENT:

The authors thank the authorities of the CDRI, Lucknow for spectral and analytical data

 

REFERENCES:

1.      Howland, U.S Pat., 1949, 2,458,780.

2.      Flett, U.S Pat., 1949, 2, 469, 378.

3.      Usii and Matsunura, Yogugabu Zasshi, 1967, 87, 38.

4.      Fujisowa, Pharmaceutical Col. Ltd. Japan, 1964, 67, 108

5.      M.S.R. Murthy and E. Venkata Rao, Indian Drugs, 1985, 22(9), 462-464.

6.      V.K. Ahluwalia, U.Dutt and H.R. Sharma, J.Indian Chem. Soc., 1987, LXIV, 221-223

7.      Herrmann and Goblike, Cancer Chemotherapy reports, 1961, 14, 85.

8.      Pershin, Nootskaya, Kostand and Grandberg , Dokl. Akad. Nauk, U.S.S.R., 1959, 123, 200.

9.      A.M. Farghaly, I.Chaaban, S.M. Fahmy and A.E. Bistawroos (Fac. Phar., Univ. Alexandria, Egypt), Alexandria, J.Pharm. Sci., 1989, 3(2), 170-173; C.A. 1991, 114, 61993v.

10.    A.M. Farghaly, I.Chaaban,S.M. EI-Khawas and S.M. Fahmy (Fac. Phar., Univ. Alexandria, Egypt), J.Chin. Chem. Soc. (Taipei), 1990, 37(5), 501-509; C.A. 1991; 114, 81691y.

11.    Viehlyaev, Grandberg and Kost, Formakol, 1, Toksikol., 1962, 25, 27.

12.    Y. Murakimi, M.Taraka, H. Morita, H.Obata and K. Takagi, Jpn. Kokai, Tokyo Koho, JP 6172, 758, 86, 72, 758 through Chem. Abs.,  1986, 105, 208876j.

13.    H.G. Garg and N.Kaur, J. Med. Chem., 1972, 15, 554.

14.    Wolf, U.S. Pat., 8 Nov. 1966, 3284,464.

15.    Danek and Nousova , Collect, Czech, Commun., 1968, 33(2), 425

16.    Anderson, U.S. Pat., 1968, 2, 107,321


 

 

 

Received on 04.04.2009        Modified on 20.05.2009

Accepted on 11.06.2009        © AJRC All right reserved

Asian J. Research Chem.  2(2): April.-June, 2009 page 1-3